Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that remains incurable, despite decades of basic and clinical research. Key stakeholders—including the US National ...

According to Dr. Shemesh, the findings suggest that tau protein ... such as Parkinson's disease and amyotrophic lateral sclerosis (ALS). The World Health Organization indicates that most of ...

ndcn.ox.ac.uk Objective To use an unbiased method to test a previously reported association between cerebral arteriovenous malformation (AVM) embolisation and the subsequent development of amyotrophic ...

Introduction The prescription of an intervention plan can be challenging for the physical therapist, considering clinical phenotypes, individual prognosis and the rapid, progressive and deteriorating ...

Objective To evaluate the efficacy and safety of intramuscular ultra-high-dose methylcobalamin in patients with amyotrophic lateral sclerosis (ALS ... with the higher dose of methylcobalamin. These ...

We also compared MRI findings with FDG uptake in the same muscle regions. Further, we compared SUVmax in proximal muscles between patients with PM/DM and those with amyotrophic lateral sclerosis (ALS) ...

Introduction: T regulatory cells (Tregs) inversely correlate with disease progression in Amyotrophic Lateral Sclerosis (ALS ... we recognize these findings merely “scratch the surface” of a much more ...

targeting calpain-2 for people living with amyotrophic lateral sclerosis (ALS). With the clinical hold lifted, Amylyx is now working to open U.S. sites for screening, enrollment, and dosing.

Acute clinical events with stable MRI were more likely among patients ... better outcomes among patients with multiple sclerosis (MS). New findings show a similar number of injective-related ...